MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.

Loss of retinal ganglion cells (RGCs) in optic neuropathies results in permanent partial or complete blindness. Myocyte enhancer factor 2 (MEF2) transcription factors have been shown to play a pivotal role in neuronal systems, and in particular MEF2A knockout was shown to enhance RGC survival after...

Full description

Bibliographic Details
Main Authors: Xin Xia, Caroline Y Yu, Minjuan Bian, Catalina B Sun, Bogdan Tanasa, Kun-Che Chang, Dawn M Bruffett, Hrishikesh Thakur, Sahil H Shah, Cara Knasel, Evan G Cameron, Michael S Kapiloff, Jeffrey L Goldberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0242884
_version_ 1811309063543193600
author Xin Xia
Caroline Y Yu
Minjuan Bian
Catalina B Sun
Bogdan Tanasa
Kun-Che Chang
Dawn M Bruffett
Hrishikesh Thakur
Sahil H Shah
Cara Knasel
Evan G Cameron
Michael S Kapiloff
Jeffrey L Goldberg
author_facet Xin Xia
Caroline Y Yu
Minjuan Bian
Catalina B Sun
Bogdan Tanasa
Kun-Che Chang
Dawn M Bruffett
Hrishikesh Thakur
Sahil H Shah
Cara Knasel
Evan G Cameron
Michael S Kapiloff
Jeffrey L Goldberg
author_sort Xin Xia
collection DOAJ
description Loss of retinal ganglion cells (RGCs) in optic neuropathies results in permanent partial or complete blindness. Myocyte enhancer factor 2 (MEF2) transcription factors have been shown to play a pivotal role in neuronal systems, and in particular MEF2A knockout was shown to enhance RGC survival after optic nerve crush injury. Here we expanded these prior data to study bi-allelic, tri-allelic and heterozygous allele deletion. We observed that deletion of all MEF2A, MEF2C, and MEF2D alleles had no effect on RGC survival during development. Our extended experiments suggest that the majority of the neuroprotective effect was conferred by complete deletion of MEF2A but that MEF2D knockout, although not sufficient to increase RGC survival on its own, increased the positive effect of MEF2A knockout. Conversely, MEF2A over-expression in wildtype mice worsened RGC survival after optic nerve crush. Interestingly, MEF2 transcription factors are regulated by post-translational modification, including by calcineurin-catalyzed dephosphorylation of MEF2A Ser-408 known to increase MEF2A-dependent transactivation in neurons. However, neither phospho-mimetic nor phospho-ablative mutation of MEF2A Ser-408 affected the ability of MEF2A to promote RGC death in vivo after optic nerve injury. Together these findings demonstrate that MEF2 gene expression opposes RGC survival following axon injury in a complex hierarchy, and further support the hypothesis that loss of or interference with MEF2A expression might be beneficial for RGC neuroprotection in diseases such as glaucoma and other optic neuropathies.
first_indexed 2024-04-13T09:35:05Z
format Article
id doaj.art-89aa8b9a176d4afeb696a4458a3febf9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T09:35:05Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-89aa8b9a176d4afeb696a4458a3febf92022-12-22T02:52:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011512e024288410.1371/journal.pone.0242884MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.Xin XiaCaroline Y YuMinjuan BianCatalina B SunBogdan TanasaKun-Che ChangDawn M BruffettHrishikesh ThakurSahil H ShahCara KnaselEvan G CameronMichael S KapiloffJeffrey L GoldbergLoss of retinal ganglion cells (RGCs) in optic neuropathies results in permanent partial or complete blindness. Myocyte enhancer factor 2 (MEF2) transcription factors have been shown to play a pivotal role in neuronal systems, and in particular MEF2A knockout was shown to enhance RGC survival after optic nerve crush injury. Here we expanded these prior data to study bi-allelic, tri-allelic and heterozygous allele deletion. We observed that deletion of all MEF2A, MEF2C, and MEF2D alleles had no effect on RGC survival during development. Our extended experiments suggest that the majority of the neuroprotective effect was conferred by complete deletion of MEF2A but that MEF2D knockout, although not sufficient to increase RGC survival on its own, increased the positive effect of MEF2A knockout. Conversely, MEF2A over-expression in wildtype mice worsened RGC survival after optic nerve crush. Interestingly, MEF2 transcription factors are regulated by post-translational modification, including by calcineurin-catalyzed dephosphorylation of MEF2A Ser-408 known to increase MEF2A-dependent transactivation in neurons. However, neither phospho-mimetic nor phospho-ablative mutation of MEF2A Ser-408 affected the ability of MEF2A to promote RGC death in vivo after optic nerve injury. Together these findings demonstrate that MEF2 gene expression opposes RGC survival following axon injury in a complex hierarchy, and further support the hypothesis that loss of or interference with MEF2A expression might be beneficial for RGC neuroprotection in diseases such as glaucoma and other optic neuropathies.https://doi.org/10.1371/journal.pone.0242884
spellingShingle Xin Xia
Caroline Y Yu
Minjuan Bian
Catalina B Sun
Bogdan Tanasa
Kun-Che Chang
Dawn M Bruffett
Hrishikesh Thakur
Sahil H Shah
Cara Knasel
Evan G Cameron
Michael S Kapiloff
Jeffrey L Goldberg
MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.
PLoS ONE
title MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.
title_full MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.
title_fullStr MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.
title_full_unstemmed MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.
title_short MEF2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury.
title_sort mef2 transcription factors differentially contribute to retinal ganglion cell loss after optic nerve injury
url https://doi.org/10.1371/journal.pone.0242884
work_keys_str_mv AT xinxia mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT carolineyyu mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT minjuanbian mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT catalinabsun mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT bogdantanasa mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT kunchechang mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT dawnmbruffett mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT hrishikeshthakur mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT sahilhshah mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT caraknasel mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT evangcameron mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT michaelskapiloff mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury
AT jeffreylgoldberg mef2transcriptionfactorsdifferentiallycontributetoretinalganglioncelllossafteropticnerveinjury